FDA issued a Warning Letter to Lifecore Biomedical, Inc. on 10/8/2004 for a previous inspection.
483 Lifecore Biomedical Feb 2019

483 Lifecore Biomedical Feb 2019

Scott Golladay FDA, Ross Grigsby FDA$119.00 - Available Now

FDA investigators audited the Lifecore Biomedical - Chaska, MN, United States facility and issued inspectional observations (via FDA 483) on 26 Feb 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 26 Feb 2019
  • Location: Chaska, United States
  • FEI: 1000115753
Add To Cart